{"id":"W2345027487","doi":"10.1038/bjc.2016.72","title":"Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours","year":2016,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Cell death mechanisms and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":149,"is_retracted":false,"has_abstract":true,"ca_institutions":"WSP (Canada)","funders":"","keywords":"Refractory (planetary science); Prodrug; Medicine; Internal medicine; Oncology; Clinical trial; Phases of clinical research; Cancer research; Pharmacology; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000513422,0.0001394143,0.0004103661,0.00009083386,0.00002383917,0.00001318674,0.0001386303,0.00009617864,0.00002391103],"category_scores_gemma":[0.0003323239,0.00009651188,0.0001159735,0.0001247907,0.00007633778,0.0000190859,0.00001761605,0.0001395831,1.927373e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005335676,"about_ca_system_score_gemma":0.000347161,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005853006,"about_ca_topic_score_gemma":0.001835193,"domain_scores_codex":[0.9982052,0.00009746673,0.0009448082,0.0002591136,0.0002798694,0.0002135664],"domain_scores_gemma":[0.9985068,0.00006292998,0.0008604135,0.0001510098,0.0003241941,0.00009458906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.533333,0.007101793,0.007942939,0.00009236857,0.0002645721,0.0002030944,0.00005893512,0.001795724,0.1935066,0.000001658774,0.0004263921,0.2552729],"study_design_scores_gemma":[0.6982318,0.01881926,0.05386794,0.003420068,0.0001639798,0.00005170547,0.0000547701,0.0001612251,0.208951,0.00001978402,0.01568128,0.0005772325],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978781,0.0004291541,0.000687013,0.0001273049,0.0002563748,0.0004961037,0.0001061471,0.000002127144,0.00001770701],"genre_scores_gemma":[0.9982367,0.0005284689,0.0009006068,0.00003601546,0.0001277223,0.0000174993,0.00002400758,0.00002423639,0.000104731],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2546957,"threshold_uncertainty_score":0.393564,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.024082570526279,"score_gpt":0.3349164922363005,"score_spread":0.3108339217100216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}